Details of the Drug

General Information of Drug (ID: DMBHBJP)

Drug Name
FCX-007
Indication
Disease Entry ICD 11 Status REF
Dystrophic epidermolysis bullosa EC32 Phase 1/2 [1]
Cross-matching ID
TTD ID
D0WC4Y

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)